X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$3.26
+2.45%
Mkt Cap $315.29M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$11.50
Range $11.00 – $12.00
Implied Upside
+253.0%
Consensus $11.50 vs current $3.26
NASDAQ·Healthcare·Biotechnology
$3.26
+2.45%
Mkt Cap $315.29M
No recent rating data.
Price Target (10 analysts)
$11.50
Range $11.00 – $12.00
+253.0%
Consensus $11.50 vs current $3.26